Literature DB >> 20595668

Vascular and degenerative processes differentially affect regional interhemispheric connections in normal aging, mild cognitive impairment, and Alzheimer disease.

Dong Young Lee1, Evan Fletcher, Oliver Martinez, Natalia Zozulya, Jane Kim, Jeannie Tran, Michael Buonocore, Owen Carmichael, Charles DeCarli.   

Abstract

BACKGROUND AND
PURPOSE: Despite the critical importance of the corpus callosum (CC) to the connection between brain hemispheres, little is known about the independent contribution of degenerative and vascular processes to regional changes in the microstructural integrity of the CC. Here, we examine these changes in subjects with mild cognitive impairment, with Alzheimer disease, and in cognitively normal elderly adults.
METHODS: We used 3-dimensional brain MRI with diffusion tensor imaging in 47 Alzheimer disease, 77 mild cognitive impairment, and 107 cognitively normal subjects, and we calculated mean fractional anisotropy (FA) values for 4 CC regions corresponding to 4 homologous regions of cortical gray matter (GM). To assess vascular and degenerative processes, we also measured cortical GM and white matter hyperintensity (WMH) volume in corresponding regions and evaluated their vascular risk.
RESULTS: We found that GM volumes in anterior and posterior regions were significantly related to FA values in the corresponding regions of the CC for all 3 diagnostic groups. Independent of GM volume, frontal WMH volume was also associated with FA values in the corresponding CC regions, but posterior WMH volume was not. Vascular risk was associated with FA of most CC regions, whereas diagnosis of cognitive state was associated only with FA of the anterior and posterior CC regions.
CONCLUSIONS: We found differential region-specific associations between degenerative and vascular processes and the structural integrity of the CC across the spectrum of cognitive ability. Based on these results, we propose a model to explain regional disruption in the interhemispheric connection.

Entities:  

Mesh:

Year:  2010        PMID: 20595668      PMCID: PMC2922914          DOI: 10.1161/STROKEAHA.110.582163

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  18 in total

1.  Regional spatial normalization: toward an optimal target.

Authors:  P Kochunov; J L Lancaster; P Thompson; R Woods; J Mazziotta; J Hardies; P Fox
Journal:  J Comput Assist Tomogr       Date:  2001 Sep-Oct       Impact factor: 1.826

Review 2.  The role of the corpus callosum in interhemispheric transfer of information: excitation or inhibition?

Authors:  Juliana S Bloom; George W Hynd
Journal:  Neuropsychol Rev       Date:  2005-06       Impact factor: 7.444

3.  Voxel-based detection of white matter abnormalities in mild Alzheimer disease.

Authors:  S Xie; J X Xiao; G L Gong; Y F Zang; Y H Wang; H K Wu; X X Jiang
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

4.  Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease.

Authors:  R C Pearson; M M Esiri; R W Hiorns; G K Wilcock; T P Powell
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

Review 5.  Cellular aspects of callosal connections and their development.

Authors:  G M Innocenti; D Aggoun-Zouaoui; P Lehmann
Journal:  Neuropsychologia       Date:  1995-08       Impact factor: 3.139

6.  Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden.

Authors:  Charles DeCarli; Evan Fletcher; Vincent Ramey; Danielle Harvey; William J Jagust
Journal:  Stroke       Date:  2004-12-02       Impact factor: 7.914

Review 7.  Selective vulnerability of neocortical association areas in Alzheimer's disease.

Authors:  P Giannakopoulos; P R Hof; C Bouras
Journal:  Microsc Res Tech       Date:  1998-10-01       Impact factor: 2.769

8.  Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers.

Authors:  H C Chui; J I Victoroff; D Margolin; W Jagust; R Shankle; R Katzman
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

9.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

10.  Stroke risk modifies regional white matter differences in mild cognitive impairment.

Authors:  Lisa Delano-Wood; Mark W Bondi; Amy J Jak; Nikki R Horne; Brian C Schweinsburg; Lawrence R Frank; Christina E Wierenga; Dean C Delis; Rebecca J Theilmann; David P Salmon
Journal:  Neurobiol Aging       Date:  2008-11-11       Impact factor: 4.673

View more
  47 in total

1.  White matter hyperintensity penumbra.

Authors:  Pauline Maillard; Evan Fletcher; Danielle Harvey; Owen Carmichael; Bruce Reed; Dan Mungas; Charles DeCarli
Journal:  Stroke       Date:  2011-06-02       Impact factor: 7.914

2.  Influence of functional connectivity and structural MRI measures on episodic memory.

Authors:  Jing He; Owen Carmichael; Evan Fletcher; Baljeet Singh; Ana-Maria Iosif; Oliver Martinez; Bruce Reed; Andy Yonelinas; Charles Decarli
Journal:  Neurobiol Aging       Date:  2012-01-27       Impact factor: 4.673

3.  The contributions of MRI-based measures of gray matter, white matter hyperintensity, and white matter integrity to late-life cognition.

Authors:  J He; V S S Wong; E Fletcher; P Maillard; D Y Lee; A-M Iosif; B Singh; O Martinez; A E Roach; S N Lockhart; L Beckett; D Mungas; S T Farias; O Carmichael; C DeCarli
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-26       Impact factor: 3.825

4.  Education amplifies brain atrophy effect on cognitive decline: implications for cognitive reserve.

Authors:  Dan Mungas; Brandon Gavett; Evan Fletcher; Sarah Tomaszewski Farias; Charles DeCarli; Bruce Reed
Journal:  Neurobiol Aging       Date:  2018-04-12       Impact factor: 4.673

5.  Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury.

Authors:  Charles DeCarli; Sylvia Villeneuve; Pauline Maillard; Danielle Harvey; Baljeet Singh; Owen Carmichael; Evan Fletcher; John Olichney; Sarah Farias; William Jagust; Bruce Reed; Dan Mungas
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

6.  A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology.

Authors:  Michael L Alosco; Michael A Sugarman; Lilah M Besser; Yorghos Tripodis; Brett Martin; Joseph N Palmisano; Neil W Kowall; Rhoda Au; Jesse Mez; Charles DeCarli; Thor D Stein; Ann C McKee; Ronald J Killiany; Robert A Stern
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 7.  Telomere shortening and Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-11-16       Impact factor: 3.843

Review 8.  Clinically asymptomatic vascular brain injury: a potent cause of cognitive impairment among older individuals.

Authors:  Charles DeCarli
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

9.  An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease.

Authors:  Lidia Sarro; Nirubol Tosakulwong; Christopher G Schwarz; Jonathan Graff-Radford; Scott A Przybelski; Timothy G Lesnick; Samantha M Zuk; Robert I Reid; Mekala R Raman; Bradley F Boeve; Tanis J Ferman; David S Knopman; Giancarlo Comi; Massimo Filippi; Melissa E Murray; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Clifford R Jack; Kejal Kantarci
Journal:  Alzheimers Dement       Date:  2016-08-10       Impact factor: 21.566

10.  Subgroup of ADNI normal controls characterized by atrophy and cognitive decline associated with vascular damage.

Authors:  Jasmine Nettiksimmons; Laurel Beckett; Christopher Schwarz; Owen Carmichael; Evan Fletcher; Charles Decarli
Journal:  Psychol Aging       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.